0752 DR (Asacol 400 mg)
Generic Name: mesalamine
Pill with imprint 0752 DR is Brown, Capsule-shape and has been identified as Asacol 400 mg. It is supplied by Allergan, Inc..
Asacol is used in the treatment of ulcerative colitis; crohn's disease; inflammatory bowel disease; ulcerative colitis, maintenance; crohn's disease, maintenance (and more), and belongs to the drug class 5-aminosalicylates. Excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Asacol 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 0752 DR



Asacol
- Generic Name:
- mesalamine
- Imprint:
- 0752 DR
- Strength:
- 400 mg
- Color:
- Brown
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- 5-aminosalicylates
- Pregnancy Category:
- B - No proven risk in humans - excluding Asacol and Asacol HD
C - Risk cannot be ruled out - Asacol and Asacol HD - CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Allergan, Inc.
- Inactive Ingredients:
- silicon dioxide
dibutyl phthalate
ferric oxide red
ferric oxide yellow
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:2)
polyethylene glycol
povidone
sodium starch glycolate type A potato
magnesium silicate
Note: Inactive ingredients may vary.
More about Asacol (mesalamine)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- 53 Reviews – Add your own review/rating
- Drug class: 5-aminosalicylates
Consumer resources
Other brands: Lialda, Pentasa, Apriso, Delzicol, ... +5 more
Professional resources
Other Formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.